#AUA14 - Poster: Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7

ORLANDO, FL USA (UroToday.com) - Presented by Matthew Cooperberg, Stephen J. Freedland, Thorsten Schlomm, Julia E. Reid, Steven Stone, and Michael K. Brawer at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua2014 prolaris cooperberg poster thumb

Myriad Genetic Laboratories, Inc., Salt Lake City, UT; University of California, San Francisco, San Francisco, CA; Duke University Medical Center and Durham VA Medical Center, Durham, NC; University Medical Center Hamburg-Eppendorf, Hamburg,Germany; Myriad Genetics, Inc., Salt Lake City, UT

Click HERE to listen to an interview with Matthew R. Cooperberg, MD, MPH, one of the authors of this study




Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.